Bmi-1 Promotes Glioma Angiogenesis by Activating NF-κB Signaling

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Jiang, Lili ^a   Song, Libing ^b   Wu, Jueheng ^c,d   Yang, Yi ^c,d   Zhu, Xun ^c,d   Hu, Bo ^e   Cheng, Shi Yuan ^e   Li, Mengfeng ^c,d  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY   (China)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; VASCULOTROPIN C;

ANGIOGENESIS; ARTICLE; BINDING SITE; CELL MIGRATION; CHORIOALLANTOIS; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE SILENCING; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; PHENOTYPE; POLYMERASE CHAIN REACTION; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE;

ANIMALS; CELL LINE, TUMOR; CHICK EMBRYO; ENZYME ACTIVATION; GENE EXPRESSION; GENE SILENCING; GLIOMA; HUMANS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; POLYCOMB REPRESSIVE COMPLEX 1; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TRANSPLANTATION, HETEROLOGOUS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 84873101131     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055527     Document Type: Article

References (44)

1. Carmeliet P, (2005) Angiogenesis in life, disease and medicine. Nature 438: 932-6.
2. Folkman J, (2002) Role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15-8.
3. Ferrara N, (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2: 795-803.
4. Bauer AL, Jackson TL, Jiang Y, (2007) A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis. Biophys J 92: 3105-21.
5. Taylor LP, (2010) Diagnosis, treatment, and prognosis of glioma: five new things. Neurology 75: S28-32.
6. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, et al. (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-96.
7. Clarke J, Butowski N, Chang S, (2006) Recent advances in therapy for glioblastoma. Arch Neurol 67: 279-83.
8. Miyagami M, Katayama Y, (2005) Angiogenesis of glioma: evaluation of ultrastructural characteristics of microvessels and tubular bodies (Weibel-Palade) in endothelial cells and immunohistochemical findings with VEGF and p53 protein. Med Mol Morphol 38: 36-42.
9. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, et al. (2007) Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev 21: 2683-710.
10. Ribatti D, Vacca A, (2008) The role of microenvironment in tumor angiogenesis. Genes Nutr 3: 29-34.
11. Cea V, Sala C, Verpelli C, (2012) Antiangiogenic therapy for glioma. J Signal Transduct 2012: 483040.
12. Leon SP, Folkerth RD, Black PM, (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77: 362-72.
13. Birlik B, Canda S, Ozer E, (2006) Tumour vascularity is of prognostic significance in adult, but not paediatric astrocytomas. Neuropathol Appl Neurobiol 32: 532-8.
14. Song LB, Li J, Liao WT, Feng Y, Yu CP, et al. (2009) The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626-36.
15. Vonlanthen S, Heighway J, Altermatt HJ, Gugger M, Kappeler A, et al. (2001) The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer 84: 1372-6.
16. Zhang FB, Sui LH, Xin T, (2008) Correlation of Bmi-1 expression and telomerase activity in human ovarian cancer. Br J Biomed Sci 65: 172-7.
17. Chowdhury M, Mihara K, Yasunaga S, Ohtaki M, Takihara Y, et al. (2007) Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia. Leukemia 21: 1116-22.
18. Guo BH, Feng Y, Zhang R, Xu LH, Li MZ, et al. (2011) Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer 10: 10.
19. Li DW, Tang HM, Fan JW, Yan DW, Zhou CZ, et al. (2010) Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer. J Cancer Res Clin Oncol 136: 997-1006.
20. van Lohuizen M, Verbeek S, Scheijen B, Wientjens E, van der Gulden H, et al. (1991) Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 65: 737-52.
21. Song LB, Zeng MS, Liao WT, Zhang L, Mo HY, et al. (2006) Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Res 66: 6225-32.
22. Li J, Gong LY, Song LB, Jiang LL, Liu LP, et al. (2011) Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway. Am J Pathol 176: 699-709.
23. Jacobs JJ, Kieboom K, Marino S, DePinho RA, van Lohuizen M, (1999) The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397: 164-8.
24. Dhawan S, Tschen SI, Bhushan A, (2009) Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev 23: 906-11.
25. Lindstrom MS, Klangby U, Wiman KG, (2001) p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53. Oncogene 20: 2171-7.
26. Liu S, Dontu G, Mantle ID, Patel S, Ahn NS, et al. (2006) Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 66: 6063-71.
27. Jiang L, Li J, Song L, (2009) Bmi-1, stem cells and cancer. Acta Biochim Biophys Sin (Shanghai) 41: 527-34.
28. Jiang L, Mao P, Song L, Wu J, Huang J, et al. (2010) miR-182 as a prognostic marker for glioma progression and patient survival. Am J Pathol 177: 29-38.
29. Jiang L, Lin C, Song L, Wu J, Chen B, et al. (2012) MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB/IkappaBalpha negative feedback loop. J Clin Invest 122: 33-47.
30. Zilberberg L, Shinkaruk S, Lequin O, Rousseau B, Hagedorn M, et al. (2003) Structure and inhibitory effects on angiogenesis and tumor development of a new vascular endothelial growth inhibitor. J Biol Chem 278: 35564-73.
31. Shin HM, Kim MH, Kim BH, Jung SH, Kim YS, et al. (2004) Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation. FEBS Lett 571: 50-4.
32. Meng X, Wang Y, Zheng X, Liu C, Su B, et al. (2012) shRNA-mediated knockdown of Bmi-1 inhibit lung adenocarcinoma cell migration and metastasis. Lung Cancer.
33. Xu CR, Lee S, Ho C, Bommi P, Huang SA, et al. (2009) Bmi1 functions as an oncogene independent of Ink4A/Arf repression in hepatic carcinogenesis. Mol Cancer Res 7: 1937-45.
34. Holland EC, (2001) Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet 2: 120-9.
35. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, et al. (2001) Malignant glioma: genetics and biology of a grave matter. Genes Dev 15: 1311-33.
36. Zhu Y, Parada LF, (2002) The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2: 616-26.
37. Sanai N, Alvarez-Buylla A, Berger MS, (2005) Neural stem cells and the origin of gliomas. N Engl J Med 353: 811-22.
38. Orpana A, Salven P, (2002) Angiogenic and lymphangiogenic molecules in hematological malignancies. Leuk Lymphoma 43: 219-24.
39. Chilov D, Kukk E, Taira S, Jeltsch M, Kaukonen J, et al. (1997) Genomic organization of human and mouse genes for vascular endothelial growth factor C. J Biol Chem 272: 25176-83.
40. Yan C, Wang H, Aggarwal B, Boyd DD, (2004) A novel homologous recombination system to study 92 kDa type IV collagenase transcription demonstrates that the NF-kappaB motif drives the transition from a repressed to an activated state of gene expression. Faseb J 18: 540-1.
41. Hong TM, Teng LJ, Shun CT, Peng MC, Tsai JC, (2009) Induced interleukin-8 expression in gliomas by tumor-associated macrophages. J Neurooncol 93: 289-301.
42. Yu Q, Stamenkovic I, (2000) Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 14: 163-76.
43. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, et al. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2: 737-44.
44. Brat DJ, Bellail AC, Van Meir EG, (2005) The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro Oncol 7: 122-33.